Biomedtracker

What Biomedtracker does

Biomedtracker is a B2B subscription intelligence platform that tracks and analyzes clinical and regulatory events for the pharmaceutical and biotech industries. Its core offering is a web-based platform that aggregates and analyzes data on drugs, companies, diseases, clinical trials, regulatory events, and market intelligence across 881 disease indications spanning 20 therapy areas including oncology, neurology, immunology, cardiovascular, metabolic, and rare diseases. The platform provides tools for tracking catalysts, impact events, FDA Advisory Committee meetings, KOL interviews, and market analytics, supplemented by a Report Library of 1,993 reports covering disease analyses, market spotlights, pricing and reimbursement, strategy, conference coverage, and KOL insights. The technology integrates Datamonitor Healthcare content and provides advanced search capabilities across catalysts, companies, drugs, events, deals, FDA AdComm meetings, KOLs, and trial comparisons.

The company is operated by Pharma Intelligence UK Limited and is part of the Norstella portfolio alongside Evaluate, Datamonitor Healthcare, Pharmapremia, and Meddevicetracker. Biomedtracker's go-to-market is enterprise field sales targeting large pharmaceutical companies, biotech firms, and biotech investors/analysts, with direct outreach, demo requests, and a client services team. The platform is accessed via subscription with quote-based annual pricing, and customers can purchase Biomedtracker standalone or as part of cross-product bundles within the Norstella ecosystem.

Biomedtracker's value proposition centers on real-time clinical event tracking, approval likelihood predictions, KOL qualitative insights, and comprehensive market intelligence to support drug pipeline and investment decisions. The platform serves pharmaceutical companies (clinical development strategy, competitive intelligence), biotech investors and analysts (due diligence, pipeline assessment), biotechnology companies (market intelligence), and healthcare consultants (research and analysis). Its marketing approach combines content marketing (report library, disease analyses, KOL publications), event-driven content (ASCO and other major conference coverage), and direct enterprise sales. The company is headquartered in London, UK, and serves a global customer base with primary markets in the US, UK, Germany, and France.

Name

Biomedtracker

Legal name

Pharma Intelligence UK Limited

Website

https://biomedtracker.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

1–10 employees

Short description

Biomedtracker is a B2B subscription intelligence platform that tracks clinical and regulatory events across 881 disease indications for pharmaceutical companies, biotech firms, and biotech investors. Operated as part of the Norstella portfolio alongside Evaluate and Datamonitor Healthcare, it provides real-time catalyst tracking, KOL insights, and a 1,993-report intelligence library on annual enterprise subscriptions.

Ownership category

akta.pro rank

Product category

Pharmaceutical Intelligence Software

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

• Pharmaceutical intelligence
• Clinical trial tracking
• Drug development analytics
• Regulatory event monitoring
• Biotech market research

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Subscription Intelligence Services: Biomedtracker operates as a subscription-based SaaS platform providing pharmaceutical intelligence services to enterprise customers. Access to reports, KOL Insight transcripts, and data analytics requires paid subscription. Multiple product tiers exist including Biomedtracker standalone, Datamonitor Healthcare integration, and cross-product access within the Norstella portfolio (Evaluate, Datamonitor Healthcare, Pharmapremia, Meddevicetracker).

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Biomedtracker is a subscription-based, web-delivered pharmaceutical intelligence platform that provides real-time tracking of drug development catalysts, clinical trial results, regulatory decisions, FDA Advisory Committee activity, and deal events across 881 disease indications. It combines a proprietary impact-event methodology for approval likelihood forecasting with an integrated Report Library of Datamonitor Healthcare disease analyses, market spotlights, KOL interview transcripts, pricing/reimbursement reports, and major conference coverage (ASCO, ESMO, AACR), sold to enterprise pharma, biotech, and investor clients under annual subscription agreements.

Product overview

Biomedtracker is a comprehensive pharma intelligence platform operated by Norstella (Evaluate) that provides real-time tracking and analysis of drug development catalysts, clinical events, regulatory decisions, and deal activity. The platform operates as a unified system with interconnected modules including the core Biomedtracker Platform, Report Library (with Datamonitor Healthcare reports covering Disease Reports, Market Spotlights, PharmaVitae, Pricing & Reimbursement, Strategy, and Conference Reports), Pharma Intelligence Disease Hub (joint coverage with Datamonitor Healthcare across 881 indications), Catalyst Tracking, Impact Events, Deals Intelligence, Regulatory Insights, Advanced Search capabilities, KOL Insight Reports, and Latest Pharma Insights news aggregation. The platform serves pharmaceutical and biotech industry professionals with subscription-based access to intelligence covering companies, drugs, diseases, trials, targets, events, deals, catalysts, and reports.

Differentiator

Problem solved

Functional benefit

Brands

• Datamonitor Healthcare: Healthcare market intelligence reports and disease analysis modules offered within the Biomedtracker platform

Products and services

• Biomedtracker Platform
• Pharma Intelligence Disease Hub Joint coverage platform combining Biomedtracker and Datamonitor Healthcare disease data, providing comprehensive disease intelligence across 881 indications with market spotlights, disease analyses, and forecasts for subscribers.
• Report Library Subscription-accessed collection of healthcare intelligence reports including Datamonitor Healthcare Disease Reports, Market Spotlight Reports, KOL Insight Reports, Conference Reports, PharmaVitae Reports, and Regulatory & Therapeutic Area Reports, covering 1,993 reports across multiple therapy areas.

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• NorstellacoreStrategic or Co-development PartnerBiomedtracker is a product within the Norstella company portfolio, which includes Evaluate (drug approval tracking and analytics), Datamonitor Healthcare (market intelligence), Pharmapremia (pricing and reimbursement intelligence), and Meddevicetracker (medical device intelligence). Norstella operates Pharma Intelligence UK Limited as the operating entity for Biomedtracker, with integrated cross-product offerings and shared infrastructure.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Evaluate (Norstella): Parent company within Norstella and a direct peer offering drug approval tracking, consensus forecasts, and pharma commercial intelligence. Overlapping customer base and product functionality in pharma/biotech intelligence subscriptions.
• Citeline (Pharma Projects): Sister product under Norstella providing drug pipeline intelligence, clinical trial tracking, and regulatory analysis. Directly comparable in pharma intelligence scope and customer base, both serve enterprise pharma and biotech with subscription-based clinical/regulatory intelligence.
• Clarivate (Cortellis): Major pharma intelligence platform offering competitive intelligence, drug pipeline data, patent analytics, and clinical trial insights. Direct competitor in serving pharma R&D and business development teams with subscription intelligence.
• Informa Pharma Intelligence: Historical owner of Biomedtracker and current operator of competing pharma intelligence brands (Scrip, Medtech Insight, HBW Insight). Direct competitor in pharma news, clinical trial, and regulatory intelligence subscriptions.
• GlobalData Pharmaceutical: Provides pharma market intelligence, clinical trial databases, drug pipeline analytics, and epidemiology data. Direct competitor in pharma/biotech subscription intelligence for enterprise customers.
• Adis International: Pharma intelligence publishing brand under Springer Nature providing drug evaluation, clinical trial summaries, and pharmacoeconomic analysis. Comparable in providing subscription-based clinical and commercial intelligence to pharma/biotech.

Emerging players

• AlphaSense: AI-powered market intelligence platform with expanding pharma/biotech content coverage. Emerging competitor using generative AI to disrupt traditional pharma intelligence aggregators like Biomedtracker.
• Definitive Healthcare: Healthcare commercial intelligence provider with overlap in pharma pipeline, clinical development, and healthcare provider analytics. Adjacent competitor for pharma commercial and competitive intelligence use cases.

Broad incumbents

• S&P Capital IQ Pro (Biopharma): Broad financial data platform with biopharma pipeline, clinical trial, and biotech company intelligence modules. Incumbent serving biotech investors and analysts with adjacent product coverage.
• IQVIA (formerly QuintilesIMS): Broad incumbent in pharma services, R&D, and commercial intelligence with extensive data assets overlapping Biomedtracker's clinical trial and market intelligence. Larger portfolio player with broader scope.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/biomedtracker
• LinkedInlinkedin.com/company/biomedtracker

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomedtracker